相关实验视频
Updated: Jun 3, 2025

07:44
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
27.1K
复制综合征:基于人工智能的诊断,严重程度尺度的发展和与临床和分子变量相关的相关性
Lourdes Vega-Hanna1, Dídac Casas-Alba1, Sol Balsells2
1Genetics Department, Hospital Sant Joan de Déu, Member of ERN-ITHACA, 08950 Esplugues de Llobregat, Spain.
Diagnostics (Basel, Switzerland)
|January 11, 2025
概括
这项研究开发了一种临床严重程度尺度 (MECPDup),并使用人工智能诊断MECP2重复综合征 (MDS),改善对这种罕见的神经发育障碍的理解和管理.
科学领域:
- 遗传学和罕见疾病.
- 神经发育障碍 神经发育障碍
- 与X相关的遗传条件
背景情况:
- MECP2重复综合征 (MDS) 是一种罕见的X相关神经发育障碍.
- 具有智力障碍,低血压,自闭症谱系障碍和发育回归的特征.
- 通常表现为复发性呼吸道感染,消化不良和发作.
研究的目的:
- 为MECP2重复综合征 (MDS) 开发一种特定的临床严重程度尺度.
- 探索尺度与临床和分子变量之间的相关性.
- 使用Face2Gene平台自动进行MDS诊断.
主要方法:
- 对35名经遗传确认的MDS患者 (2012-2024) 的回顾性研究.
- 开发和验证标准化临床问卷 (MECPDup规模).
- 训练Face2Gene算法使用患者照片进行自动诊断.
主要成果:
- 确定了关键特征:智力障碍 (100%),低血压 (93%),自闭症 (77%),回归 (52%).
- 验证了MECPDup规模,与MBA规模相关;男性和早期死亡者得分更高.
- Face2Gene算法成功训练用于MDS识别;MECPDup与年龄和重复大小相关联.
结论:
- 对MECP2重复综合征的全面临床和分子见解.
- 基于AI的面部识别和MECPDup尺度提高了诊断准确性和疾病监测.
- 为改善MDS患者的护理和治疗评估提供有前途的工具.
更多相关视频
09:16Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
19.5K
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.6K
相关概念视频
Karyotyping
57.3K
Overview
57.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K